Blog

Dr. Miguel Zugman received a 2025 KCA Trailblazer Award in partnership with Kure It Cancer Research for research on "Stool microbiome assessment in a randomized phase I trial of nivolumab and ipilimumab with or without EXL01 in the first-line treatment of metastatic renal cell carcinoma (mRCC)". Dr. Zugman is a postdoctoral research fellow at City of Hope Comprehensive Cancer Center…

The Kidney Cancer Association (KCA) awarded over half a million dollars in research grants to six investigators pursuing high-impact kidney cancer research through the annual KCA Research Award Program and partnerships. Each award supports early- to mid-career investigators researching topics that require greater attention and understanding across the kidney cancer community. The KCA distributed a total of $525,000 in research…

The Kidney Cancer Association (KCA) and the American Society for Radiation Oncology (ASTRO) partnered for a special joint session during the annual ASTRO meeting on September 30 in San Francisco, California. The session brought together an international, multidisciplinary panel of experts to discuss the emerging role of stereotactic ablative radiotherapy (SABR), a highly focused form of radiation therapy, to the…

We rounded up a few research highlights from the 2025 Congress of the European Society for Medical Oncology (ESMO), held recently in Berlin, Germany. Is a triplet of drugs a superior first-line treatment strategy? Among four different combinations of first-line triplet therapy for advanced kidney cancer, all including pembrolizumab, one showed promising efficacy compared with the reference study arm in which patients…

The Kidney Cancer Association (KCA) welcomes KidneyCouch as a new Affiliate Partner. Jeff Kallis KidneyCouch is committed to offering support and information to individuals battling kidney cancer and/or chronic kidney disease (CKD) with a goal to create a community that fosters connection, understanding, and empowerment for patients and their loved ones. Founder Jeff Kallis, 64, was diagnosed with stage 3…

This is a guest post by Tom Green, 60, who was diagnosed with stage 4 kidney cancer in 2015. He is currently a business owner, a new student at McDaniel College in Maryland, and a member of the McDaniel Green Terror football team. He lives with his family in Pennsylvania. Read a story about him at the Baltimore Sun. Up…

The Kidney Cancer Association partnered with Moffitt Cancer Center to highlight stories of resilience and hope in the face of kidney cancer. Supported by the compassionate care and leading research innovation at Moffitt, people diagnosed with kidney cancer describe their journeys through diagnosis, treatment, and beyond. Moffitt is a National Cancer Institute-designated Comprehensive Cancer Center where top research and care…

The Kidney Cancer Association (KCA) welcomes Elevate Childhood Cancer Research and Advocacy (Elevate) as a new Affiliate Partner organization. Elevate’s mission is to dramatically improve the lives of those diagnosed with childhood cancer from diagnosis through treatment, supporting their whole life journey whether through terminal illness or survivorship. “Elevate is committed to ensuring that every child has access to precision…

The 2025 International Kidney Cancer Symposium: North America will feature three special awards honoring standout members of the kidney cancer community. The meeting will take place in Denver, Colorado from November 13-15. Register now. Dr. Michael Jewett Dr. Michael Jewett receives the Nicholas J. Vogelzang Humanitarian Award, named in honor of the KCA's late co-founder and Board member, for outstanding…

The Kidney Cancer Association (KCA) hosted the first-ever workshop to gather leading researchers from around the world, including two Nobel Prize winners, and discuss how to accelerate kidney cancer research at the preclinical stage to better understand this cancer and bring better treatments and diagnostic tools to patients.   The Renal Cell Carcinoma (RCC) Animal Model Workshop was hosted in partnership…